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ABSTRACT
Endocytosis as an Additional Mechanism of Glucose Transport to
the Hexose Transporter in Trypanosoma brucei
JongSu Choi
Department of Chemistry and Biochemistry, BYU
Master of Science
Trypanosoma brucei is an extracellular kineotoplastid parasite that causes human African
trypanosomiasis (HAT), also known as sleeping sickness. As trypanosomes undergo vector to host
transition, heavy transcriptional adaptation such as metabolic shift to glycolysis and upregulated
endocytosis occurs. Specifically, glycolysis in the infectious stage becomes the sole source of
energy production; thus, the glucose transport mechanism in T. brucei provides one of the most
promising therapeutic targets for development of new drugs to treat HAT. Despite an established
trypanosome hexose transporter (THT) model for glucose transport across the plasma membrane,
there remains gaps in the detailed mechanism of glucose transport especially as it relates to glucose
transport across the glycosomal membrane. Using 2-NBDG, a fluorescent glucose analog, we
measured glucose uptake rates in the presence of small molecule inhibitors and by using RNA
interference (RNAi) to knockdown key proteins to investigate the mechanism of glucose transport
in trypanosomes. We have confirmed a direct role of THT in glucose transport of BSF
trypanosomes; however, in our investigations, we observed an unexpected ATP-dependence on
glucose transport in live trypanosomes, which initiated further study where we focused on the role
of endocytosis as an ATP-coupled bulk glucose transport mechanism. Experimental approaches
that inhibited endocytosis reduced the observed glucose uptake rate confirming a role for
endocytosis-coupled glucose transport in BSF trypanosomes. We provide evidence for an
endocytosis-coupled glucose transport mechanism in BSF trypanosomes as an additional and
important mechanism that functions in parallel with the established THT model.

Keywords: Trypanosoma brucei, sleeping sickness, trypanosome hexose transporter, THT,
glucose transport, endocytosi
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1. Introduction
1.1 Kinetoplastids
T. brucei is an extracellular kinetoplastid parasite. Having diverged early in eukaryotic
evolution, kinetoplastids are a group of flagellated protists that are characterized by a unique
organelle named the kinetoplast that contains many copies of the mitochondrial DNA or kDNA
[1],[2],[3]. Kinetoplastids include disease-causing parasitic species such as Leishmania donovani,
Trypanosoma cruzi, and Trypanosoma brucei[4]. Leishmania donovani is an intracellular parasite
transmitted by species of sand fly throughout tropical and temperate regions including Africa,
China, India, Europe and South America and causes visceral leishmaniasis, also known as the
black fever. Trypanosoma cruzi is transmitted by the feces of the “kissing bug” in South and
Central America and causes Chagas disease. Trypanosoma brucei, the organism of our study, is
transmitted by tsetse flies in Sub-Saharan Africa and is a causative agent of human African
trypanosomiasis, or African sleeping sickness and animal trypanosomiasis, also called nagana in
cattle and horses[4]. T. brucei is divided into three major subspecies: T. b. gambiense, T. b.
rhodensiense, and T. b. brucei. Human infection occurs via T. b. gambiense, and T. b.
rhodensiense, whereas T. b. brucei infects only non-primate mammals. Notably, infection by T. b.
rhodensiense causes rapid manifestation of trypanosomiasis symptoms. T. b. gambiense, on the
other hand, causes a chronic infection that goes unnoticed for a long time in the majority of cases
but still accounts for 95% of reported cases [4]. T. b. brucei, in contrast to the two human
pathogens, is susceptible to Trypanosome Lytic Factor (TLF), a high-density lipoprotein in human
blood and possess no pathogenic properties in humans [5]. Thus, with similar genetic make-ups
amongst three subspecies, T. b. brucei serves as a model organism for studies in many laboratories.
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1.2 T. brucei lifecycle
T. brucei has a complex lifecycle. As a fly takes a blood meal from an infected individual,
bloodstream form (BSF) trypanosomes in the mammalian host transition into a proliferative
procyclic form (PF) trypanosomes in the midgut of the fly. PF trypanosomes in the midgut then
rapidly divide to become epimastigotes, which eventually arrest their cell cycles and migrate
toward the salivary gland of the fly where they become the infective metacyclic trypomastigotes.
Starting as the long slender form of BSF upon initial inoculation in the mammalian host, BSF
trypanosomes proliferate and transition into dormant stumpy form arrested in G1 phase, which
then transition back into the midgut of the tsetse fly for the next full cycle [6]. Because of the
drastic environmental changes that trypanosomes face in their life cycle, trypanosomes change and
adapt their morphology and their transcriptional regulation to best suit their environment. PF
trypanosomes possess a fully functional mitochondrion and utilize proline and other amino acids
as well as glucose for their metabolism. Their cell surface is also covered with a dense proline-rich
acidic repetitive protein, named procyclin that are linked by a glycosylphosphatidylinositol (GPI)
anchor [7]. Once transitioned to the bloodstream, however, trypanosomes lose their functional
mitochondrion and convert their energy production solely to glycolysis [8-12]. The procyclin
covering the surface of PF cells is also replaced with highly immunogenic VSG molecules that are
constantly recycled in BSF cells. BSF cells harbor more than 1000 different copies of VSG in the
genome, of which only one variant is expressed at once [13, 14]. By having more than one variant
being expressed at once in mixed population, BSF cells negate the existing antibodies that
recognize the specific VSG antigen [15].
1.3 T. brucei differentiation
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Up to 25% of all transcripts are expected to be regulated during the differentiation of
trypanosome [16-18]. In addition, the differentiation from BSF to PF is triggered by the
environmental change from the mammalian host to the fly. In vitro, however, the differentiation
can be triggered by the addition of cis-aconitate facilitated by both the cis-aconitate transporters
and temperature shift from 37°C to 29°C [19, 20]. Notably, PF differentiation from BSF can also
be induced by the removal of glucose in the media, of which inhibition of glucose transporters by
phloretin was also shown to have similar effect [21, 22].
Trypanosomes express two families of its surface-associated hexose transporters for its
glucose uptake: THT1 and THT2 [23, 24]. In PF cells, which do not require glucose for their
survival, THT2 is predominantly expressed with very little THT1. Upon introduction to the
bloodstream of the mammalian host, where rich glucose is available, THT1 becomes the dominant
form of hexose transporter, with downregulated THT2 expression in BSF cells [24].
1.4 Glycolysis in T. brucei
BSF trypanosomes rely exclusively on glycolysis for its ATP production, making a
constant 5mM glucose concentration in the bloodstream a perfect environment to thrive [25]. In
contrast, the insect stage of PF trypanosomes is capable of producing ATP through both the
glycolysis pathway as well as the respiratory Krebs cycle [26, 27]. Nevertheless, glycolysis in both
lifecycle stages of trypanosomes occurs in a unique peroxisome like-organelle called the
glycosome [28]. In the glycosome, where more than 90% of the protein content consists of
glycolytic enzymes, the first several steps of glycolysis take place to produce 3-phosphoglycerate
(3-PGA). Further degradation of 3-PGA to pyruvate then occurs in the cytosol [29, 30]. Under
aerobic conditions, the NADH produced in glycolysis is used to reduce dihydroxyacetone
3

phosphate (DHAP) to glycerol 3-phosphate (Gly-3-P). Gly-3-P is subsequently reoxidized to
DHAP by molecular oxygen via glycerol-3-phophate oxidase (GPO) in the mitochondria to
generate proton-motive force in the oxidative phosphorylation process. DHAP is then returned
back to glycosomes [31]. Under anaerobic condition, on the other hand, Gly-3-P is converted to
glycerol in exchange for one ATP molecule in the glycosome. Glycerol is then excreted into the
cytosol [32]. Interestingly, phosphoglycerate kinase (PGK), the last enzyme in producing 3-PGA,
is localized in the glycosomes in BSF, while PF harbors PGK in the cytosol [33]. In glycosomes,
there is no net production of ATP; 2 ATP molecules are produced by PGK and subsequently
balanced by hexokinase (HK) and phosphofructokinase (PFK) ATP consumption. In the cytosol,
however, the final product of glycosomal glycolysis, 3-PGA, is metabolized into pyruvate via
pyruvate kinase (PYK), which results in net one ATP production. As a result, aerobic conditions
in BSF produces 2 molecules of ATP per glucose molecule through reoxidation of NADH by
trypanosome alternative oxidase and glycerol-3-phosphate dehydrogenase, while anaerobic
condition produces one molecule of ATP per glucose molecule in BSF [25].
1.5 T. brucei glucose transport
1.5.1 Glucose transport as the rate-limiting step in glycolysis
The importance of glucose for survival of BSF parasites, glucose transport in T. brucei has
been extensively studied. First, glucose transport in BSF trypanosomes has been proposed to be a
non-energy dependent carrier-mediated pathway and not free diffusion [34, 35]. Moreover, the
glucose transport step has been further suggested as the rate-limiting step of glycolysis in BSF
trypanosomes [36]. The flux control coefficient of glucose transport across the membrane has been
identified to be between 0.3 and 0.5 at the normal 5 mM glucose concentration in blood [37]. When
4

the external glucose concentration is lower than 5 mM, the glycolytic rate does not exceed rate at
which the BSF cells take up glucose through its plasma membrane; hence, the glucose transport
step is the rate-limiting step only at external glucose concentrations lower than 5 mM. When
external glucose concentration is higher than 5mM, the glycolytic rate becomes overtaken by rate
at which hexokinase phosphorylates its glucose substrate or the uptake to the glycosomes [31].
1.5.2 Substrate specificity of hexose transporter
Extensive characterization of the structure-activity relationships of glucose transport in
trypanosomes has been done [35, 38, 39]. The substrate specificity of BSF transporters
demonstrates that hydroxyl groups located on C-3 and C-4 are important, while C-2 and C-6 are
more lenient on the transport [38]. Though not as strict in terms of substrate specificity, PF
transporters also show preference for the C-3 hydroxyl group [39]. Significant structural
differences in trypanosome glucose transporters can be identified by comparison with the
mammalian glucose transporter GLUT1. In addition to the substrate recognition ability which
allows transport of

D-fructose

in the trypanosome transporter, pharmacological differences

between the transporters demonstrates a 1000-fold stronger inhibition by cytochalasin B and
phloretin on GLUT1 compared to parasite counterparts [33]. Despite the unique biology of
trypanosomes compared to the mammalian host, no viable drugs targeted against the trypanosome
glucose transporter other than cytochalasin B and phloretin have been identified.
1.5.3 Trypanosome hexose transporters (THT)
Two functionally distinct modes of glucose transport are relevant in kinetoplastids:
facilitated diffusion and active transport coupled with ion or ATP [40]. Studies done in PF have
demonstrated that THT2 has significantly higher affinity for its hexose substrates than THT1.
5

Furthermore, THT2 activity is identified to be sensitive to proton ionophores such as FCCP at low
substrate concentration, suggesting that THT2 may be a proton coupled glucose transport [41].
The effect of proton coupled THT2 transport was, however, not noticed in a higher substrate
concentration from a study done later [39]. No effect of proton or ions have been observed in THT1
of BSF cells. In a study done in a reconstituted liposome from BSF cells, glucose transport of
THT1 was characterized as an ATP-independent facilitated diffusion with severe inhibition upon
cytochalasin B and phloretin treatment [34]. As cytochalasin B and phloretin are well known
inhibitors of GLUT1 a facilitated diffusion transporter, the idea that THT1 is a facilitated diffusion
carrier has been acknowledged.
1.5.4 Trypanosome hexose transport isoform members
Trypanosome hexose transport (THT) has been universally accepted as the only glucose
transporter in T. brucei. Sharing a high similarity to Pro-1 glucose transporter from Leishmania
enriettii, two isoforms of THTs are transmembrane proteins belonging to glucose transporter
superfamily exemplified by facilitated diffusion glucose transporter GLUT1 [24]. The notable
differential expression of the two different families in each lifecycle stage reflects differences in
the availability of environmental glucose in the mammalian host and fly vector. Complicating the
assessment of THT function, the T. brucei 427 genome harbors five putative copies of each family
member (THT1-, THT1E, THT1.3, THT1.4, THT1.5 and THT2.1, THT2.2, THT2.3, THT2.4, and
THT2A) on chromosome 10. Family membership is based on the high predicted sequence identity
shared amongst members [42, 43]. In PF parasites, THT1-, THT1.4, THT2.2, and THT2A are the
most abundant THT1 and THT2 family member transcripts, respectively. In BSF, on the other
hand, THT2.2 and THT2A are the most abundant THT2 family. All THT1 family members are
expressed at the similar level in BSF parasites.
6

1.5.5 Expression and cellular distribution of THT
Differential regulation of the transporters reflects the characteristics of the two different
transporters and the environment they are adapted to in regards to glucose. Glucose transporters
from Leishmania mexicana, a kinetoplastid parasite related to the African trypanosome, are
localized to both the flagellum and the pellicular plasma membrane [44, 45]. To assess the
localization of representative THT1 and 2 family members in T. brucei, THT1E and THT2A were
expressed with a C-terminal eYFP fusion and fluorescence and imaged using a confocal
microscopy. (Figure 1) Images of cytosolic eYFP and THT1 and THT2 fusion at the coronal plane
cross section demonstrate that both THT1 and THT2 fusions are primarily surface-associated,
while cytosolic eYFP has punctuation illuminating the whole cytosol. The representative fusion
THT proteins reveal that THT is indeed localized on the plasma membrane. The finding
demonstrates that THT proteins are transmembrane proteins alike the expected structure and
topology of an established facilitated diffusion carrier. These findings parallel those reported from
the Tryptag database (Tb927.10.8440, 8450, 8510, 8520).

7

eYFP

THT2.eYFP

THT1.eYF

BSF

Figure 1. Confocal cross section image of THT eYFP fusions and cytosolic eYFP in BSF cells.
Images of BSF cells expressing THT1E.eYFP, THT2A.eYFP, and cytosolic eYFP were fixed
with 4% paraformaldehyde PBS solution and imaged on a confocal microscope. Vertical cross
section images reveal localization of THT1E.eYFP and THT2A.eYFP fusions are surface
associated, while eYFP is localized mainly in the cytosol.

1.6 General role of endocytosis in T. brucei
Endocytosis, the ability of cells to internalize extracellular material, is a fundamental
property of any eukaryotic cell and crucial for many cellular processes such as nutrient uptake,
cell-cell communication, and cellular defense. Subsequently, endocytosis is also essential in
trypanosomes [46]. BSF trypanosomes, in fact, have one of the highest endocytosis rates known
in all eukaryotes [47, 48]. As an extracellular parasite, the BSF lifecycle stage is under constant
pressure from the host’s immune system elicited by the immunogenic VSG. As a way to evade the
host’s immune system, the infectious BSF parasites continuously and rapidly recycle the antibodyVSG complexes through endocytosis and degrade endocytosed VSG-antibody complexes in
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lysosomes [49, 50]. T. brucei mediates its endocytosis through a clathrin-dependent pathway
originating in the flagellar pocket, a small invagination of the plasma membrane in the posterior
of the cell. The endocytic rate is equivalent to the internalization of the entire flagellar pocket every
1-2 minutes [47, 48]. With trypanosomes swimming in the anterior direction, the sweeping
movement caused by the hydrodynamic flow of the extracellular fluid further enhances localized
endocytosis occurring within the flagellar pocket [13]. Clathrin knockdown trypanosomes exhibit
no detectable endocytosis, indicating that trypanosomes primarily employ clathrin-mediated
endocytosis [46]. Furthermore, inhibition of endocytosis through clathrin knockdown resulted in
cell death suggesting the crucial role endocytosis plays in T. brucei’s survival. In addition,
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], a molecule that plays a crucial function in
eukaryotic endocytosis, has also been identified to play a similarly important role in trypanosome
endocytosis. Thus, PIP kinase, which is responsible for generating PI(4,5)P2, is an important
regulator of endocytosis. Knockdown of PIP kinase leads to depletion of PI(4,5)P2 and
enlargement of flagellar pocket resulted from impaired endocytosis [51]. Interestingly, the
mammalian adaptor protein 2 (AP-2), which interacts with PI(4,5)P2 and facilitates cargo selection
and clathrin pit formation in the mammalian counterparts, is not present in the T. brucei genome;
instead, the trypanosome homologs AP-1 and AP-3 are speculated to replace AP-2 activity in
trypanosomes [52, 53]. Taken together, endocytosis is an essential cellular function in
trypanosomes.
1.7 Monitoring metabolites in T. brucei
Glucose measurements have been previously made using constitutively expressed Forster
Resonance energy transfer (FRET) biosensors in both lifecycle stages of trypanosomes [54]. Using
the FRET biosensor, accurate glucose concentrations in both the cytosol and the glycosome were
9

determined. Furthermore, a molecular pH sensor has been targeted to the glycosome and accurately
calibrated to measure the slight acidification of the glycosome upon glucose depletion [55]. The
link between pH and glucose implicates a complex glucose regulation. Thus, by non-destructively
monitoring important metabolites such as glucose, pH, and ATP in the cytosol and various
organelles, a detailed mechanism of glucose regulation in T. brucei can be deduced. Our lab has
expressed a FRET biosensor in T. brucei that is sensitive to ATP cytosolic changes in both BSF
and PF trypanosomes. In addition, various biosensors capable of measuring pH, ATP/ADP ratio,
and oxidation level are currently being developed to be expressed in trypanosomes. Such
biosensors could be used to measure changes in important metabolites and enhance the
understanding of glucose transport system in trypanosomes.
2. Experiments - endocytosis coupled glucose transport in T. brucei
2.1 Results
2.1.1 Effect of glucose transporter inhibitors on 2-NBDG uptake
To demonstrate the ability to quantitatively measure altered rates of glucose uptake, cells
were incubated with the fluorescent glucose analog 2-NBDG (300μM) and the rate of glucose
uptake was scored by measuring the intracellular 2-NBDG fluorescence using flow cytometry
following removal of the remaining extracellular 2-NBDG. As a proof of concept, phloretin and
cytochalasin B, the only known glucose uptake inhibitors in trypanosomes, were used as positive
controls for glucose uptake inhibition. In both lifecycle stages, incubation with phloretin and
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cytochalasin B (1mM and 100uM respectively) in HMI9 media resulted in significant decrease in
2-NBDG uptake response as expected (Figure 2).
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1.2
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0.8

*

0.6
0.4
0.2

No Treatment

Phloretin

0.0

Cytochalasin B

(a)
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Phloretin

Cytochalasin B

(b)

Figure 2. 2-NBDG uptakes in phloretin and cytochalasin B treated BSF and PCF cells. (a)
Phloretin and cytochalasin B, known glucose transport inhibitors in T. brucei, were used to inhibit
2-NBDG uptake in BSF cells. 2-NBDG uptake was decreased by ~30% and ~50% in phloretin
and cytochalasin B (1mM and 100uM) treated cells, respectively. (b) Phloretin and cytochalasin
B (1mM and 100uM) also inhibit 2-NBDG uptake in PCF. 2-NBDG uptake was decreased by
~40% and ~50% in PCF cells. Error bars represent the standard deviation for n = 3 replicates.
*
p< .05.

2.1.2 Impact of silencing the THT on transcript abundance and glucose uptake
To demonstrate the glucose transport ability of the THT carriers, both isoforms of THT
were silenced using tetracyclin inducible RNAi system in BSF. Silencing THT1 and THT2
individually in BSF parasites led to a significant (50%) transcript abundance reduction in each
isoform. Interestingly, silencing THT2 alone in BSF parasites led to a marked 2-fold increase in
THT1 transcript suggesting compensatory roles THT1 and THT2 have on each other. THT1, with
a low affinity (Km ~1mM), does the bulk of glucose transport in BSF parasites in glucose rich
environment, compared to THT2 with high affinity (Km ~50 μM) [39, 56]. Inadequate expression
level of THT2 in BSF, thus, may force the organism to overexpress the lower affinity form
11

transporter to overcompensate for the low glucose environment it may encounter. Additionally,
simultaneously silencing both THT1 and THT2 yielded in similar reduction of each transcript
abundance as to when each isoforms were silenced individually. Surprisingly, RNAi-based
silencing of THT1, THT2 or both transporters simultaneously resulted in no detectable impact on
growth of BSF parasites. No growth defect in BSF upon silencing both THTs was unexpected,
given the absolute reliance of the parasite on glucose for ATP production. Despite the incomplete
knockout of the genes, given the essential role of THT as the proposed sole mode of glucose
transport, the absolute lack of growth defect observed upon silencing of THT is suggestive of an
additional mode of glucose transport mechanism present in BSF parasites.
Furthermore, 2-NBDG uptake scores were measured in BSF cells with both transporters
knockdown. Silencing both transporters in BSF parasites resulted in a reduction of 2-NBDG
uptake, with a maximum reduction of ~60% after four days of induction (Figure 3). As expected
for the established hexose transporter, the reduction in 2-NBDG uptake rate undoubtedly provides
evidence for levels of THT’s involvement in glucose transport. Nonetheless, assessment of the
expected rate of transport inhibition from the RNAi silencing is difficult due to its incomplete
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geneknockout. Furthermore, evidence of no growth defect in transporter silenced trypanosomes
indicates a need for an additional glucose transport pathway that bypasses the transporters.

1.2
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Figure 3. 2-NBDG uptake rates in double THT1 and THT2 knockdown BSF cells. BSF cells were
pulsed with 2-NBDG in HMI9 media for 30 minutes and analyzed on flow cytometer. Induction
of RNAi to silence THT expression resulted in significant reduction in 2-NBDG uptake with
maximum of ~60% reduction in cells induced for 4 days. Decreased 2-NBDG uptake in THT
silenced cells provide evidence for THT’s glucose transport ability in BSF trypanosomes. Error
bars represent the standard deviation for n = 3 replicates. *p< .05.

2.1.3 Effect of ATP depletion on glucose uptake
Having observed no growth defect in THT knockdown BSF parasites, detailed study of
glucose transport mechanism was conducted in search of an additional glucose transport bypassing
the THT carriers. Previous reports have concluded that no co-transported ions or energy
requirements (i.e. ATP-dependence) are necessary for glucose uptake in reconstituted membranes
from BSF parasites [34]. We began to confirm this part of the existing model of glucose transport
13

in live cell BSF parasites by assessing the effects of ATP depletion in BSF parasites using 2-NBDG
uptake. ATP reduction was achieved by a 30-minute starvation in glucose-free PBS, whereas
normal ATP levels were maintained in PBS containing 10mM glucose; the ATP reduction was
confirmed by the use of BSF cells expressing the AT1.03YEMK FRET biosensor sensitive to
changes in ATP [57]. Cells incubated in glucose-free PBS displayed a decreasing FRET ratio
plateauing at ~20 minutes, signifying the reduction of cytosolic ATP level. Cells incubated in PBS
containing 10mM glucose, in contrast, displayed a stably high FRET ratio up to more than an hour
(Figure 4). Both ATP reduced and normal cells were then washed 2 times in glucose-free PBS and
pulsed with 2-NBDG for one minute. In ATP reduced cells, 2-NBDG uptake rate was reduced by
40% in BSF parasites, directly contradicting the previous study done in a reconstituted membrane
system in the absence of ATP (Figure 4) [34].
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Figure 4. 2-NBDG uptake in ATP depleted BSF cells and ATP level measured by AT1.03YEMK
FRET biosensor. (a) Method of ATP reduction was confirmed using AT1.03YEMK FRET
biosensor. BSF cells expressing the biosensor were washed into PBS containing 10mM glucose
(high ATP) and glucose-free PBS (low ATP), and their FRET ratios (FRET/YFP) were monitored
for an hour. Stably high FRET ratio was observed in cells incubating in 10mM glucose (high
ATP). FRET ratio decreased in cells incubating in glucose-free PBS (low ATP), eventually
plateauing after ~20 minutes. (b) 2-NBDG uptake was measured in ATP reduced BSF cells. Low
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ATP was achieved by starving BSF parasites in glucose-free PBS for 30 minutes, while high ATP
control was maintained in PBS containing 10mM glucose. Followed by a quick wash in glucosefree PBS twice, cells were pulsed with 2-NBDG for 1 minute and analyzed on the flow cytometer.
2-NBDG uptake in ATP reduced cells were significantly reduced in comparison to the ATP high
control, suggesting ATP coupled glucose transport in BSF cells. 2-NBDG uptake is normalized
to the high control. Error bars represent the standard deviation for n = 3 replicates. *p< .05.

2.1.4 ATP coupled nutrient transport bypassing the THT
The contradiction between our evidence supporting ATP-coupled glucose transport and the
previous findings may be explained by the distinction between a live cell and a reconstituted
membrane. Based on the assumption that glucose transport is facilitated by an ATP-coupled
cellular function bypassing the passive THT, the effect of endocytosis on glucose transport was
studied. In T. brucei, few specific endocytosis inhibitors have been identified, demonstrating a
direct relationship of endocytosis and glucose transport difficult. Nevertheless, we scored 2-NBDG
uptake rates in BSF cells under various conditions that have been previously established to result
in altered endocytosis rates. First, we used addition of sucrose as a means of controlling the
endocytosis rate; artificially increasing osmolality via media alteration has shown to create
abnormal formation of microcages to inhibit endocytosis by rendering clathrin unavailable for
assembly into normal coated pits [58]. 2-NBDG as well as conjugated dextran uptake rates were
measured in PBS solutions containing different concentrations of sucrose [58]. As expected,
uptake of conjugated dextran, a general marker for fluid-uptake during endocytosis was
significantly reduced as sucrose concentration increased (Figure 5). Interestingly, uptake of 2NBDG similarly decreased with increasing sucrose concentration (Figure 5). If endocytosis were
involved in glucose transport pathway of trypanosomes, the effect of endocytosis inhibition would
result in hindered glucose uptake rate. Thus, the finding that inhibition of endocytosis via
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hypertonic sucrose also decreased the 2-NBDG uptake demonstrates the involvement of
endocytosis in glucose transport.
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Figure 5. 2-NBDG and dextran-CascadeBlue uptake rates of BSF cells in hypertonic sucrose
buffers. Hypertonic sucrose buffers were used to increase osmolality and inhibit endocytosis.
Cells were incubated in buffers containing different concentration of sucrose and pulsed with 2NBDG and dextran for 1 minute and 5 minutes, respectively. Both 2-NBDG and dextran uptakes
were significantly reduced in increasing sucrose concentration with the same trend, suggesting
that inhibition of endocytosis results in decreased glucose transport rate. Error bars represent the
standard deviation for n = 3 replicates. *p< .05. #p<.05.

2.1.5 Impact of silencing endocytosis in glucose uptake
To measure the direct effect of endocytosis in glucose uptake, a genetic approach was used in
which the endocytic pathway was inhibited by silencing two genes in BSF parasites: clathrin and
PIP kinase. Both clathrin and PIP kinase have been previously silenced and demonstrated to have
essential roles in endocytosis and survival, of which clathrin silencing exhibited “big-eye”
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phenotype with the enlarged flagellum pocket where the endocytosis exclusively occurs [46, 51].
Silencing either clathrin and PIP kinase resulted in drastic reduction (~50%) of 2-NBDG uptake
in the infectious lifecycle stage, providing and solidifying direct evidence for the involvement of
endocytosis in glucose transport mechanism. Due to the morphological changes and severe growth
defect in silencing these essential genes, viability of both non-induced and induced parasites were
tested in parallel using propidium iodide. This cell viability test revealed that morphological
changes observed upon silencing of either clathrin and PIP kinase do not correlate to loss of cell
viability. Interestingly, a small and distinct population with drastically decreased 2-NBDG uptake
was observed in uninduced parasites, possibly representing leaky expression of RNAi system. As
trypanosomes are effected by the leaky expression of silencing miRNA and siRNA in uninduced
state, the small population with decreased glucose uptake demonstrates the direct effect of
inhibiting endocytosis on glucose uptake, independently of the cellular toxicity of antibiotic
tetraycyclin. The effect of dextran uptake in endocytosis knockdown cells is currently being
investigated.

2.2 Discussion
Glucose metabolism is crucial in the infectious bloodstream stage of T. brucei. While
glucose level within the human blood plasma is maintained around ~4.7 mM, glucose level in other
tissues can have vastly varying concentrations [59, 60]. Moreover, responses from host to the
infection can further alter the available glucose in different physiological locations. For instance,
in the second stage of human African trypanosomiasis when the parasites have crossed the bloodbrain barrier, glucose concentration inside the brain tissue can reach as low as 1 mM [61].
Additionally, the finding that parasites establish persistent infections in the skin, fatty tissue, and
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even testes of rodent models [62-64], areas where glucose availabilities may vastly differ, suggests
that the parasites encounter a diverse environment especially in respect to glucose availability.
Trypanosome infection has been reported to decrease host blood glucose levels [65];
furthermore, hypoglycorrhachia, or reduced glucose levels in cerebrospinal fluid, has also been
observed in human African trypanosomiasis patients and related parasitic infection in animal
models [66, 67]. Since the BSF parasites rely solely on glycolysis for its supply of ATP, the
parasites need an adaptive system that accommodates its need for higher glucose transport rate
when in a low glucose environment, such as fatty tissue or cerebral fluid. These findings point to
the parasite’s need for a dynamic system to optimize glucose uptake under different
environmental conditions, rather than a passive facilitated diffusion model, which cannot
increase uptake rate under lower glucose concentration conditions. Thus, the THT model, which
has long been proposed as the glucose transport method in T. brucei, alone is not the best way to
provide an explanation for the rugged adaptability of trypanosomes as they are exposed to
diverse environments.
Since the discovery of the genes, THT has been the universally accepted glucose
transporter in T. brucei. In fact, alongside endocytosis, THT expression is one of major
transcriptional changes trypanosomes undergo when transitioning from insect vector to the host
[16-18]. To demonstrate the glucose transport ability of THT in live BSF trypanosomes, both
isoforms of THT were knockdown using RNAi system. As expected for a well-established carrier
protein, silencing of both THT carriers led to a reduction in glucose transport ability. Surprisingly,
despite a significant reduction in glucose uptake, no detectable growth defect was observed in THT
knockdown BSF cells. If THTs are the sole mode of glucose transport in trypanosomes, silencing
such important genes would prevail a significant hindrance on the growth of parasites. Although
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interpreting the expected amount of glucose transport reduction proves hard without complete
knockout of the genes, the lack of a lethal phenotype in THT knockdown parasites led us to reevaluate the established glucose transport mechanism in T. brucei.
In search of an additional mode of glucose transport mechanism bypassing the THT
carriers, we have found evidence supporting energy-driven glucose transport in BSF, which
directly contradicts the previous experiments done in a cell-free reconstitution system lacking
ATP, Na+ or pH gradients [34]. As the proposed facilitated diffusion carrier protein, THT should
not directly require an energy source for its function. Contrary to our findings done in live
trypanosomes, the previous findings that show THT as an ATP independent facilitated diffusion
transporter were done in a reconstituted membrane system. Our findings in live trypanosomes
suggest that an additional mode of glucose transport exists in live trypanosomes that bypasses the
ATP-independent THT present on the plasma membrane. Based on the idea that endocytosis is an
ATP coupled bulk transport process that can be inhibited by the depletion of ATP, role of
endocytosis in glucose transport was explored. Many factors involved in endocytosis are
oftentimes difficult to manipulate due to their intertwined roles in many other cellular functions.
Furthermore, with few known inhibitor of endocytosis, 2-NBDG uptake rate under hypertonic
sucrose condition was scored. Interestingly, hypertonic sucrose buffers significantly decreased 2NBDG uptake rate in BSF parasites. The effect of hypertonic sucrose on endocytosis was further
examined and confirmed using conjugated dextran. Although no specific endocytic machinery is
targeted hypertonic sucrose, the similar trend between 2-NBDG and dextran supports our claim in
endocytosis’s involvement in glucose transport. An ATP-dependent glucose transport pathway in
conjunction with evidence for decreased 2-NBDG uptake in endocytosis inhibited trypanosomes
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is strongly suggestive that endocytosis acts as an additional glucose transport pathway in parallel
with the THT.
To stay away from speculations, a direct measure of inhibiting endocytosis was used to
further strength our argument. Two genes directly involved in endocytosis, clathrin and PIP kinase,
were silenced and studied [46, 51]. Further supporting our hypothesis of glucose transport through
endocytosis, silencing endocytosis through both genes resulted in severe reduction of 2-NBDG
uptake. Silencing the essential endocytosis genes manifested morphological changes; however,
cell viability test revealed intactness of endocytosis compromised parasites. Furthermore, a small
population of significantly reduced 2-NBDG uptake was observed in uninduced control which can
be explained by the leaky expression RNAi and strengthen the argument that 2-NBDG uptake
reduces in endocytosis compromised trypanosomes. Significant reduction in 2-NBDG transport in
clathrin and PIP kinase knockdown provides strong evidence for the direct involvement of
endocytosis machinery in glucose transport pathway.
Our study has shown the involvement of endocytosis in glucose transport of T. brucei.
However, without a proper transporter or a protein identified, a mechanistic model of proposed
glucose transport pathway cannot be deduced. More detailed studies need to be done to identify
how exactly endocytosis is involved in glucose transport; whether endocytosed glucose gets
pumped out into the cytosol from the clathrin coated vesicles via a protein pump or trafficked
directly to the glycosome. Moreover, the extent of glucose transport contribution from each THT
and endocytosis is yet to be determined.

20

2.3 Materials and Methods
2.3.1 Reagents and parasite cultures
Adenosine triphosphate (ATP), and 2-deoxyglucose were purchased from Sigma (St.
Louis, MO).

2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-

NBDG), Phloretin, and cytochalasin B were purchased from Cayman Chemicals (Ann Arbor, MI).
Bloodstream form cells (BSF) 9013, a derivative of strain Lister 427, were cultured in
HMI9 media [68] consisting of 10% Serum Plus™ medium supplement (Sigma) and 10% dialyzed
fetal bovine serum (Corning). Procyclic form cells (PF) 2913 parasites (also a Lister 427
derivative) were cultured in SDM79 media [69] composed of 15% heat-inactivated fetal bovine
serum (Corning). Parasites were routinely maintained under conditions that were optimal for
logarithmic growth (1x106 – 5x106). Expression of RNAi system was induced by the addition of
doxycyclin at 1μg/ml into the media.
2.3.2 THT gene expression analysis
To assess mRNA expression of THT, log phase BSF and PF cells growing in HMI9 and
SDM79 respectively were centrifuged (1000 x g, 5 min) and gently washed three times in
phosphate buffered saline (PBS). RNA isolation of harvested cells was performed using Aurum
Total RNA Mini Kit (Bio-Rad).
Real-time quantitative PCR was performed using a Verso 1-step RT-qPCR Kit
(ThermoFisher) in a CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad). Ct values of
transcripts were used to solve relative expression by the comparative Ct (2-ΔΔCT) method using the
expression of the hypoxanthine-guanine phosphoribosyl transferase (HGPRT) gene as a control as
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described [70]. Transcripts of other house-keeping genes, including the 60S rRNA, TERT, and
18S rRNA genes, were used as internal controls. Dissociation curves were assessed for each
reaction and efficiency tests performed for all primers to guarantee specific and equally efficient
amplification.
2.3.3 RNAi lines generation
To generate RNAi lines, RT-PCR of corresponding genes were done with primers binding
on the genome, THT here, CLH there, PIPKA here. The copy DNA from RT-PCF was cloned into
the pZJM RNAi plasmid and were subsequently transfected and incorporated in the genome.
2.3.4 Confocal microscopy
BSF cells expressing THT1E-eYFP, THT2A-eYFP and eYFP in log phase were harvested
by centrifugation (1000 rpm, 5 min), washed with PBS 3 times, and resuspended in 1:1 PBS and
fix (4% formaldehyde in PBS). Cells were then transferred to slides, allowed to settle for 30
minutes, incubated with VECTASHIELD antifade mounting medium, and visualized on a with
enough z-stacks to visualize whole cells.
2.3.5 Uptake assays
To quantitatively measure glucose uptake over time, a fluorescent glucose analogy, 2NBDG was used. For 2-NBDG uptake assays, BSF and PF cells were washed in HMI9 and SDM79
media respectively 3 times followed by a 15 min incubation at the desired temperature. Labeling
was initiated by addition of 2-NBDG (300μM) with or without experimental treatments. To stop
the uptake, 1ml of ice-cold PBS containing glucose (300 mM) was added, followed by extensive
washing with ice-cold PBS. Cells were then resuspended in PBS supplemented with 10 mM
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glucose and propidium iodide (1μg/ml), and analyzed on Attune™ NxT or CytoFlex flow
cytometer at 10,000 cells.
Fluid phase endocytosis rate was measured using fluorescent dextran conjugate. Cells were
harvested and washed in desired buffer followed by the addition of dextran-CascadeBlue (5mg/ml)
in appropriate treatment conditions. To halt the reaction, 1ml of ice-cold PBS was added, followed
by extensive washing with cold PBS solution. Cells were then resuspended in PBS supplemented
with 10mM glucose and propidium iodide (1μg/ml) and analyzed on Attune™ NxT or CytoFlex
flow cytometer.
2.3.6 FFET biosensor – intracellular ATP measurement
To non-destructively measure cytosolic ATP concentrations, constitutively expressed
AT1.03YEMK [57] was cloned in expression vector pXS6 and transfected in BSF 90-13 T. brucei
427 strain. Expression in these vectors is driven from the T. brucei rRNA promoter, typically
yielding robust expression [18]. Constructs were transfected into BSF parasites using the Amaxa
Human T Cell Nucleofector Kit (Lonza, Basel, Switzerland) as described [19]. The biosensor
consists of an CFP/mVenus FRET pair flanking an ATP binding domain of Bacillus subtilis F0F1
ATP synthase subunit. The ratio of the fluorescence from a single fluorophore to the FRET ratio
that results from ATP-induced conformation change of the ATP synthase subunit allows
quantification of ATP.
For quantitative calculation of intracellular ATP concentration, cells were washed in PBS
3 times and transferred to PBS solution containing 10mM glucose for a high ATP control and
10mM sodium azide as a low ATP control. FRET/YFP ratios of cells at the maximum and
minimum ATP concentrations in PBS were measured using CytoFlex flow cytometer.
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2.4 Conclusion and Future Direction
In conclusion, data provided above demonstrate endocytosis as an additional glucose
transport pathway in BSF trypanosomes. Our findings suggest that THT may not be as crucial as
previous thought. Furthermore, with evidence supporting an additional ATP-coupled glucose
transport system that bypasses the THT in live trypanosomes, the role of endocytosis, an ATP
coupled bulk transport in glucose transport was subsequently investigated. Inhibition of
endocytosis via various means such as hypertonic media and genetic silencing has shown
decreased glucose analog uptake rates solidifies endocytosis’s role in glucose transport. The
findings presented above, however, is in its preliminary stage and require further study. A few
things need to be identified in order to provide a mechanistic model of the proposed glucose
transport pathway. Particularly, exact mechanism of endocytosis in glucose transport needs to be
identified. Although trypanosomes primarily employ clathrin-mediated endocytosis, our findings
suggest that endocytosis coupled glucose transport may occur via fluid-phase endocytosis not
affected by a receptor mediated endocytosis inhibitor. Whether a specific receptor or the sheer
volume of extracellular medium endocytosed, the mechanism in which glucose is taken up from
the flagellar pocket need a further clarification. In addition, a proper glucose transporter needs to
be identified in the endocytic compartments. As endocytic compartments are continually recycled
back and forth from the flagellar pocket to the endosome/TGN, the endocytosed glucose need a
pathway to the appropriate locations through either a transporter that pumps out glucose into the
cytosol or alterative traffic pathway into the glycosomes.

24

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

Sogin, M.L., et al., Phylogenetic meaning of the kingdom concept: an unusual ribosomal
RNA from Giardia lamblia. Science, 1989. 243(4887): p. 75-7.
Renger, H.C. and D.R. Wolstenholme, Kinetoplast and other satellite DNAs of
kinetoplastic and dyskinetoplastic strains of Trypanosoma. J Cell Biol, 1971. 50(2): p.
533-40.
Liu, B., et al., Fellowship of the rings: the replication of kinetoplast DNA. Trends
Parasitol, 2005. 21(8): p. 363-9.
Barrett, M.P., et al., The trypanosomiases. Lancet, 2003. 362(9394): p. 1469-80.
Rifkin, M.R., Identification of the trypanocidal factor in normal human serum: high
density lipoprotein. Proc Natl Acad Sci U S A, 1978. 75(7): p. 3450-4.
Matthews, K.R., The developmental cell biology of Trypanosoma brucei. Journal of Cell
Science, 2005. 118(2): p. 283-290.
Roditi, I. and M. Liniger, Dressed for success: the surface coats of insect-borne
protozoan parasites. Trends Microbiol, 2002. 10(3): p. 128-34.
Opperdoes, F.R., Compartmentation of Carbohydrate Metabolism in Trypanosomes.
Annual Review of Microbiology, 1987. 41(1): p. 127-151.
Bakker, B.M., et al., Glycolysis in Bloodstream Form Trypanosoma brucei Can Be
Understood in Terms of the Kinetics of the Glycolytic Enzymes. Journal of Biological
Chemistry, 1997. 272(6): p. 3207-3215.
Michels, P.A.M. and V. Hannaert, The evolution of kinetoplastid glycosomes. Journal of
Bioenergetics and Biomembranes, 1994. 26(2): p. 213-219.
Hannaert, V. and P.A.M. Michels, Structure, function, and biogenesis of glycosomes in
Kinetoplastida. Journal of Bioenergetics and Biomembranes, 1994. 26(2): p. 205-212.
Bakker, B.M., H.V. Westerhoff, and P.A.M. Michels, Regulation and control of
compartmentalized glycolysis in bloodstream formTrypanosoma brucei. Journal of
Bioenergetics and Biomembranes, 1995. 27(5): p. 513-525.
Engstler, M., et al., Hydrodynamic flow-mediated protein sorting on the cell surface of
trypanosomes. Cell, 2007. 131(3): p. 505-15.
Cross, G.A., L.E. Wirtz, and M. Navarro, Regulation of vsg expression site transcription
and switching in Trypanosoma brucei. Mol Biochem Parasitol, 1998. 91(1): p. 77-91.
McCulloch, R., Antigenic variation in African trypanosomes: monitoring progress.
Trends Parasitol, 2004. 20(3): p. 117-21.
Kabani, S., et al., Genome-wide expression profiling of in vivo-derived bloodstream
parasite stages and dynamic analysis of mRNA alterations during synchronous
differentiation in Trypanosoma brucei. BMC Genomics, 2009. 10: p. 427.
Queiroz, R., et al., Transcriptome analysis of differentiating trypanosomes reveals the
existence of multiple post-transcriptional regulons. BMC Genomics, 2009. 10: p. 495.
Siegel, T.N., et al., Genome-wide analysis of mRNA abundance in two life-cycle stages of
Trypanosoma brucei and identification of splicing and polyadenylation sites. Nucleic
Acids Res, 2010. 38(15): p. 4946-57.
Overath, P., J. Czichos, and C. Haas, The effect of citrate/cis-aconitate on oxidative
metabolism during transformation of Trypanosoma brucei. Eur J Biochem, 1986. 160(1):
p. 175-82.
25

20.
21.

22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.

Dean, S., et al., A surface transporter family conveys the trypanosome differentiation
signal. Nature, 2009. 459(7244): p. 213-7.
Milne, K.G., A.R. Prescott, and M.A. Ferguson, Transformation of monomorphic
Trypanosoma brucei bloodstream form trypomastigotes into procyclic forms at 37
degrees C by removing glucose from the culture medium. Mol Biochem Parasitol, 1998.
94(1): p. 99-112.
Haanstra, J.R., et al., A domino effect in drug action: from metabolic assault towards
parasite differentiation. Mol Microbiol, 2011. 79(1): p. 94-108.
Bringaud, F. and T. Baltz, A potential hexose transporter gene expressed predominantly
in the bloodstream form of Trypanosoma brucei. Mol Biochem Parasitol, 1992. 52(1): p.
111-21.
Bringaud, F. and T. Baltz, Differential regulation of two distinct families of glucose
transporter genes in Trypanosoma brucei. Mol Cell Biol, 1993. 13(2): p. 1146-54.
Bakker, B.M., et al., What controls glycolysis in bloodstream form Trypanosoma brucei?
J Biol Chem, 1999. 274(21): p. 14551-9.
Evans, D.A. and R.C. Brown, The utilization of glucose and proline by culture forms of
Trypanosoma brucei. J Protozool, 1972. 19(4): p. 686-90.
Lamour, N., et al., Proline metabolism in procyclic Trypanosoma brucei is downregulated in the presence of glucose. J Biol Chem, 2005. 280(12): p. 11902-10.
Hannaert, V. and P.A. Michels, Structure, function, and biogenesis of glycosomes in
kinetoplastida. J Bioenerg Biomembr, 1994. 26(2): p. 205-12.
Michels, P.A., et al., Metabolic functions of glycosomes in trypanosomatids. Biochim
Biophys Acta, 2006. 1763(12): p. 1463-77.
Opperdoes, F.R. and P. Borst, Localization of nine glycolytic enzymes in a microbodylike organelle in Trypanosoma brucei: the glycosome. FEBS Lett, 1977. 80(2): p. 360-4.
Bakker, B.M., et al., Glycolysis in bloodstream form Trypanosoma brucei can be
understood in terms of the kinetics of the glycolytic enzymes. J Biol Chem, 1997. 272(6):
p. 3207-15.
Hammond, D.J. and I.B. Bowman, Studies on glycerol kinase and its role in ATP
synthesis in Trypanosoma brucei. Mol Biochem Parasitol, 1980. 2(2): p. 77-91.
Blattner, J., et al., Compartmentation of phosphoglycerate kinase in Trypanosoma brucei
plays a critical role in parasite energy metabolism. Proc Natl Acad Sci U S A, 1998.
95(20): p. 11596-600.
Seyfang, A. and M. Duszenko, Functional reconstitution of the Trypanosoma brucei
plasma-membrane D-glucose transporter. Eur J Biochem, 1993. 214(2): p. 593-7.
Gruenberg, J., P.R. Sharma, and J. Deshusses, D-Glucose transport in Trypanosoma
brucei. D-Glucose transport is the rate-limiting step of its metabolism. Eur J Biochem,
1978. 89(2): p. 461-9.
Ter Kuile, B.H. and F.R. Opperdoes, Glucose uptake by Trypanosoma brucei. Ratelimiting steps in glycolysis and regulation of the glycolytic flux. J Biol Chem, 1991.
266(2): p. 857-62.
Bakker, B.M., et al., Contribution of glucose transport to the control of the glycolytic flux
in Trypanosoma brucei. Proc Natl Acad Sci U S A, 1999. 96(18): p. 10098-103.
Eisenthal, R., S. Game, and G.D. Holman, Specificity and kinetics of hexose transport in
Trypanosoma brucei. Biochim Biophys Acta, 1989. 985(1): p. 81-9.

26

39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.

Barrett, M.P., et al., Functional expression and characterization of the Trypanosoma
brucei procyclic glucose transporter, THT2. Biochem J, 1995. 312 ( Pt 3): p. 687-91.
Tetaud, E., et al., Kinetoplastid glucose transporters. Biochem J, 1997. 325 ( Pt 3): p.
569-80.
ter Kuile, B.H. and F.R. Opperdoes, Mutual adjustment of glucose uptake and
metabolism in Trypanosoma brucei grown in a chemostat. J Bacteriol, 1992. 174(4): p.
1273-9.
Bringaud, F. and T. Baltz, African trypanosome glucose transporter genes: organization
and evolution of a multigene family. Mol Biol Evol, 1994. 11(2): p. 220-30.
P., B.M., et al., Hypervariability in Gene Copy Number for the Glucose Transporter
Genes in Trypanosomes. Journal of Eukaryotic Microbiology, 1996. 43(3): p. 244-249.
Rodriguez-Contreras, D., et al., Regulation and biological function of a flagellar glucose
transporter in Leishmania mexicana: a potential glucose sensor. The FASEB Journal,
2015. 29(1): p. 11-24.
Tran, K.D., et al., Both sequence and context are important for flagellar targeting of a
glucose transporter. Journal of Cell Science, 2012. 125(14): p. 3293-3298.
Allen, C.L., D. Goulding, and M.C. Field, Clathrin-mediated endocytosis is essential in
Trypanosoma brucei. Embo j, 2003. 22(19): p. 4991-5002.
Coppens, I., et al., Receptors for the host low density lipoproteins on the hemoflagellate
Trypanosoma brucei: purification and involvement in the growth of the parasite. Proc
Natl Acad Sci U S A, 1988. 85(18): p. 6753-7.
P., W. and G. G., A novel method for mean cell volume estimation. Journal of
Microscopy, 1994. 174(2): p. 85-92.
O'Beirne, C., C.M. Lowry, and H.P. Voorheis, Both IgM and IgG anti-VSG antibodies
initiate a cycle of aggregation-disaggregation of bloodstream forms of Trypanosoma
brucei without damage to the parasite. Mol Biochem Parasitol, 1998. 91(1): p. 165-93.
Engstler, M., et al., Kinetics of endocytosis and recycling of the GPI-anchored variant
surface glycoprotein in Trypanosoma brucei. J Cell Sci, 2004. 117(Pt 7): p. 1105-15.
Demmel, L., et al., The endocytic activity of the flagellar pocket in Trypanosoma brucei
is regulated by an adjacent phosphatidylinositol phosphate kinase. J Cell Sci, 2014.
127(Pt 10): p. 2351-64.
Berriman, M., et al., The genome of the African trypanosome Trypanosoma brucei.
Science, 2005. 309(5733): p. 416-22.
Boehm, M. and J.S. Bonifacino, Genetic analyses of adaptin function from yeast to
mammals. Gene, 2002. 286(2): p. 175-86.
Voyton, C.M., et al., A FRET flow cytometry method for monitoring cytosolic and
glycosomal glucose in living kinetoplastid parasites. PLOS Neglected Tropical Diseases,
2018. 12(5): p. e0006523.
Lin, S., et al., Peptide targeted delivery of pH sensor for quantitative measurements of
intraglycosomal pH in live Trypanosoma brucei. Biochemistry, 2013. 52(21): p. 36293637.
Fry, A.J., et al., Transport of D-fructose and its analogues by Trypanosoma brucei. Mol
Biochem Parasitol, 1993. 60(1): p. 9-18.
Imamura, H., et al., Visualization of ATP levels inside single living cells with
fluorescence resonance energy transfer-based genetically encoded indicators. Proc Natl
Acad Sci U S A, 2009. 106(37): p. 15651-6.
27

58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.

Heuser, J.E. and R.G. Anderson, Hypertonic media inhibit receptor-mediated endocytosis
by blocking clathrin-coated pit formation. J Cell Biol, 1989. 108(2): p. 389-400.
Lourido, J., et al., Correlation between blood glucose concentration and glucose
concentration in subcutaneous adipose tissue evaluated with microdialysis during
intensive care. Scand J Clin Lab Invest, 2002. 62(4): p. 285-92.
Kulcu, E., et al., Physiological differences between interstitial glucose and blood glucose
measured in human subjects. Diabetes Care, 2003. 26(8): p. 2405-9.
Mulenga, C., et al., Trypanosoma brucei brucei crosses the blood-brain barrier while
tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl
Neurobiol, 2001. 27(1): p. 77-85.
Trindade, S., et al., Trypanosoma brucei Parasites Occupy and Functionally Adapt to the
Adipose Tissue in Mice. Cell Host Microbe, 2016. 19(6): p. 837-48.
Claes, F., et al., Bioluminescent imaging of Trypanosoma brucei shows preferential testis
dissemination which may hamper drug efficacy in sleeping sickness. PLoS Negl Trop
Dis, 2009. 3(7): p. e486.
Capewell, P., et al., The skin is a significant but overlooked anatomical reservoir for
vector-borne African trypanosomes. Elife, 2016. 5.
Wang, Y., et al., Global metabolic responses of mice to Trypanosoma brucei brucei
infection. Proc Natl Acad Sci U S A, 2008. 105(16): p. 6127-32.
Bisoffi, Z., et al., African trypanosomiasis gambiense, Italy. Emerg Infect Dis, 2005.
11(11): p. 1745-7.
Batista, J.S., et al., Association of Trypanosoma vivax in extracellular sites with central
nervous system lesions and changes in cerebrospinal fluid in experimentally infected
goats. Vet Res, 2011. 42: p. 63.
Hirumi, H. and K. Hirumi, Continuous cultivation of Trypanosoma brucei blood stream
forms in a medium containing a low concentration of serum protein without feeder cell
layers. J Parasitol, 1989. 75(6): p. 985-9.
Brun, R. and Schonenberger, Cultivation and in vitro cloning or procyclic culture forms
of Trypanosoma brucei in a semi-defined medium. Short communication. Acta Trop,
1979. 36(3): p. 289-92.
Schmittgen, T.D. and K.J. Livak, Analyzing real-time PCR data by the comparative C(T)
method. Nat Protoc, 2008. 3(6): p. 1101-8.

28

